Although an early case-control study3 raised the pos- sibility of a large benefit, most observational studies45 have suggested a cardiovascular benefit of about 20 percent. In such circumstances, the amount of uncon- trolled confounding in case-control or cohort studies may be as large as the small-to-moderate effects being sought 6; consequently, conclusive data can result only from a randomized trial whose sample is sufficiently large